Cure My Disease

Don't miss your cure!

 Log in / Sign up

New blood test may predict head and neck cancer outcomes

NCT ID NCT06678724

Recruiting now Knowledge-focused Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Feb 25, 2026 · Last updated May 15, 2026 · Updated 15 times

Summary

This study looks at whether a special blood test can help predict how advanced head and neck cancer will progress. Researchers will collect blood samples from 30 patients with recurrent or metastatic head and neck cancer. They will analyze cancer cells and immune cells in the blood to see if these relate to how long patients live without the disease getting worse. The goal is to better understand the disease and improve future treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • National Taiwan University HsinChu Branch

    RECRUITING

    Zhubei, HsinChu County, 302058, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

HEAD AND NECK CANCER METASTATIC HEAD AND NECK CANCERS- SQUAMOUS CELL RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA